Trials / Sponsors / Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19 Covid19 | Phase 2 | 2021-03-20 |
| Unknown | Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease Alzheimer Dementia | Phase 2 | 2016-06-01 |
| Unknown | Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging Chronic Effect of Ultraviolet Radiation on Photoaged Skin, Dermatologic Disorders | Phase 1 / Phase 2 | 2015-07-01 |
| Withdrawn | A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarctio ST Segment Elevation Myocardial Infarction (STEMI), Allogeneic Mesenchymal Bone Marrow Cells | Phase 2 | 2013-02-01 |
| Completed | A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke Ischemic Stroke | Phase 1 / Phase 2 | 2011-02-01 |